GM-CSF enhances antigen presentation ability by promoting the growth and functional maturation of dendritic cells and macrophages, thereby inducing T-cell activation and clonal proliferation within the tumor microenvironment [23,24,25]. The gene discussed is CSF2; the disease is neoplasm.